Matt S. Anderson
- Molecular Biology top 5%
- Genetics top 5%
- Organic Chemistry top 5%
- Infectious Diseases top 5%
- Molecular Medicine top 1%
- Co-authors
- Christian R.H. RaetzSuzanne S. EvelandC R RaetzSheryl A. HylandTheresa M. KellyHiroshi ŌnishiDavid L. PomplianoLynn L. Silver
- Topics
- HIV/AIDS drug development and treatment (13 papers)Glycosylation and Glycoproteins Research (11 papers)Migraine and Headache Studies (8 papers)
- Partner nations
- United StatesBelgiumGermany
In The Last Decade
Matt S. Anderson
68 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 137
- Molecular Biology 1.5k
- Genetics 703
- Organic Chemistry 493
- Infectious Diseases 400
- Molecular Medicine 356
Countries citing papers authored by Matt S. Anderson
This map shows the geographic impact of Matt S. Anderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matt S. Anderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matt S. Anderson more than expected).
Fields of papers citing papers by Matt S. Anderson
This network shows the impact of papers produced by Matt S. Anderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matt S. Anderson. The network helps show where Matt S. Anderson may publish in the future.
Co-authorship network of co-authors of Matt S. Anderson
This figure shows the co-authorship network connecting the top 25 collaborators of Matt S. Anderson. A scholar is included among the top collaborators of Matt S. Anderson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matt S. Anderson. Matt S. Anderson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 1 | |
| 3 | 4 | |
| 4 | 4 | |
| 5 | 40 | |
| 6 | 25 | |
| 7 | 14 | |
| 8 | 11 | |
| 9 | 69 | |
| 10 | 11 | |
| 11 | 18 | |
| 12 | 19 | |
| 13 | Pharmacokinetic (PK) Evaluation of Darunavir/Ritonavir (DRV/r) and Raltegravir (RAL) in Healthy Subjects | 5 |
| 14 | 206 | |
| 15 | 37 | |
| 16 | 17 | |
| 17 | 45 | |
| 18 | 13 | |
| 19 | 74 | |
| 20 | 157 |
About Matt S. Anderson
Matt S. Anderson is a scholar working on Virology, Biochemistry and Infectious Diseases, having authored 70 papers that have together received 3.1k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (13 papers), Glycosylation and Glycoproteins Research (11 papers) and Migraine and Headache Studies (8 papers). The work is most often cited by research in Molecular Medicine (356 citations), Endocrinology (222 citations) and Virology (179 citations). Matt S. Anderson has collaborated with scholars based in United States, Belgium and Germany. Frequent co-authors include Christian R.H. Raetz, Suzanne S. Eveland, C R Raetz, Sheryl A. Hyland, Theresa M. Kelly, Hiroshi Ōnishi, David L. Pompliano, Lynn L. Silver, Susan Galloway and John A. Wagner. Their work appears in journals such as Science, The Lancet and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.